Creative Planning
TNDM icon

Creative Planning’s Tandem Diabetes Care TNDM Stock Holding History

Creative Planning’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$3K – 2536
2022
Q1 		$3K Buy
+100
New +$11.7K ﹤0.01% 2287
2020
Q1 		– Sell
-3,000
Closed -$11K – 2076
2019
Q4 		$11K Buy
+3,000
New +$185K ﹤0.01% 1905

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Creative Planning's TNDM Position: Q2 2026 in Review

Creative Planning opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 16,216 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #3736 among its holdings. This is a return to the name: Creative Planning previously reported a position in TNDM as recently as Q4 2025.

Creative Planning first reported a position in TNDM in Q3 2015 and has held it in 29 quarters since. The position peaked at $1.23M in Q2 2019. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Creative Planning held 16,216 shares of Tandem Diabetes Care worth $245K as of Q2 2026.
  • Tandem Diabetes Care was a new Creative Planning position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3736 holding.
  • Creative Planning first reported a position in Tandem Diabetes Care in Q3 2015 and has held it in 29 quarters since.
  • Creative Planning's Tandem Diabetes Care position peaked at $1.23M in Q2 2019.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.